<unk>  (rINN; also known as BBR3464) is a new platinum-based cytotoxic drug that is currently undergoing clinical trials throughout the world for the treatment of human cancer. It is a trinuclear platinum coordination complex, with chloride and amine ligands. The drug acts by forming coordinate covalent adducts with cellular DNA, preventing DNA transcription and replication, and through this inducing apoptosis. It is structurally similar to, but in a different family from, the anticancer drugs cisplatin, carboplatin and oxaliplatin.
Triplatin tetranitrate
Oxydisulfoton
Indigotindisulfonate
4-Aminobenzoic acid
Diethylcarbamazine
Acetrizoic acid
Satraplatin
Isoprocarb